Anticancer Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 21.0% | 0.580 | Q2 | 66.4% |
| 2024 | 1.7 | Q4 | 20.9% | 0.545 | Q2 | 65.2% |
| 2023 | 1.6 | Q4 | 22.2% | 0.562 | Q2 | 68.7% |
| 2022 | 2.0 | Q4 | 23.4% | 0.591 | Q2 | 71.5% |
| 2021 | 2.4 | Q4 | 35.7% | 0.596 | Q2 | 72.7% |
| 2020 | — | — | 0.735 | Q2 | 77.5% | |
| 2019 | — | — | 0.716 | Q2 | 77.5% | |
| 2018 | — | — | 0.722 | Q2 | 75.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0250-7005
ISSN
1791-7530
country
GRcoverage
1981-2026